Metabolomics in Occupational Asthma

NCT ID: NCT04301674

Last Updated: 2022-08-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

80 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-10-15

Study Completion Date

2023-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The project aims to increase the diagnostic accuracy in occupational asthma (OA), with emphasis on Irritant Induced Asthma (IIA). Currently, most patients are evaluated in occupational medicine by comparing the exposure and symptom characteristics with epidemiological data. Biological markers may be present in AA, but presently not in IIA. The majority of cases evaluated are considered as possible IIA, i.e. low-dose multiple exposures. VOC features will be analyzed with the Breath Biopsy® and TD-GS-MS (Owlstone Medical Ltd, UK).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma, Occupational

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Occupational Asthma

Patients refered for assesment of occupational asthma

Breath Biopsy

Intervention Type DEVICE

ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)

Respiratory Healthy Control

Employees at Oslo University Hospital

Breath Biopsy

Intervention Type DEVICE

ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Breath Biopsy

ReCIVA breath sampler (Owlstone Medical, Cambridge, UK)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* capable of informed consent.
* asthma diagnosis established by lung specialist or healthy control.

Exclusion Criteria

* skin allergy towards plastics or rubber.
* immunocompromised by oral medication.
* contagious respiratory disease.
* biopsy of lung parenchyma within the last 36 hours.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Owlstone Ltd

INDUSTRY

Sponsor Role collaborator

Oslo University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bato Hammarstrøm

Senior consultant/Research group leader

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bato Hammarstrøm, MD/PhD

Role: PRINCIPAL_INVESTIGATOR

Oslo University Hospital

Tonje Trulssen Hildre, M.Sc.

Role: STUDY_CHAIR

Oslo University Hospital

Hilde Heiro, MD

Role: STUDY_CHAIR

Oslo University Hospital

Britt G Randem, MD/PhD

Role: STUDY_CHAIR

Oslo University Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Oslo University Hospital

Oslo, , Norway

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Norway

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Bato Hammarström, MD/PhD

Role: CONTACT

+47 230 16667

Tonje Trulssen Hildre, M.Sc.

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

UO1

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Bronchial Asthma & Its Exacerbation
NCT06331897 NOT_YET_RECRUITING